SLC6A1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

40 results for “SLC6A1”

Trials

View all 24 →

Enrolling By Invitation

Gene Therapy for SLC6A1 Neurodevelopmental Disorder

1 participants · First posted Sep 15, 2025

SLC6A1-NDD Prospective Longitudinal Natural History Study

60 participants · First posted Apr 15, 2026

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

100,000 participants · First posted Nov 10, 2010

Drugs

MLC601

SLC6A4 Inhibitors (UCSF)

SLC4A4 inhibitor (pancreatic ductal adenocarcinoma)

News

View all 12 →

4-Phenylbutyrate Shows Promise in Treating Genetic Epilepsy in Children

Nature Reviews Drug Discovery Review Positions SLC Transporters as Untapped Frontier in CNS Drug Development

Maze Therapeutics Initiates Phase 1 Trial of MZE782 for Chronic Kidney Disease

Page 1 of 4